The patient, a 76-year-old male, was on dialysis, with both of his kidneys failing and diseased, until the wrong one was removed during surgery, hospital spokeswoman Dorie Klissas told the Associated Press (AP), adding that doctors subsequently removed the second failed kidney and that the patient is doing well.

Klissas told AP: "This event should never have occurred at Mount Sinai. We apologized to the patient, and we will do all we can to ensure that something like this never happens again."

Klissas would not give the date and time that the incident occurred, nor would she provide the surgeon’s name, citing it was hospital policy not to comment about issues regarding personnel, AP reported.

Wrong-side surgeries happen at hospitals across the U.S., the AP reported, noting that many of these facilities try to make their operating rooms "mistake proof."

In July 2008, a surgeon at a Minneapolis hospital who removed a cancer patient’s wrong kidney blamed beeper calls and other patients when he made a mistake on the patient's chart, a state investigation there found, according to the AP report.

Wrong-side surgery happens frequently enough to pose a “significant risk” for many surgeons during his or her career, according to a National Center for Biotechnology Information (NCBI) study, as reported on by NatureWorldNews.com.

According to an MMM-Online.com report, the Food and Drug Administration has sent a Warning Letter to oBand Centers there regarding information on their Web site that lacks clear distinctions and descriptions of the side effects associated with its service and specifically, the Lap-Band device and the surgery to implant it. 

The FDA has been cracking down on surgery centers that offer Lap-Band, a device that is inserted around a person's stomach that's designed to severely restrict a person's appetite and promotes rapid and extensive weight loss. Lap-Band is typically only approved in rare circumstances, usually for morbidly or severely obese people. Since this restriction has not been drawing in the expected clientele volume, clinics that offer the Lap-Band procedure have resorted to a flooding of the market with advertisements for these clinics and procedure. 

In many cases, these promotionals have fallen short of FDA regulations for advertising medical devices, surgeries, or any other medical procedures that dictate how much of a product's side effects must be discussed in an ad and whether that information is readily available to would-be patients of a center. 

oBand Centers, according to several other sources, is actually a referral service for weight loss clinics that offer the Lap-Band procedure, much like the Web site 1-800-Flowers is for participating florists.

In fact, it was an aggressive billboard campaign, 1-800-GET-THIN, that first called attention to questionable marketing practices exercised by the makers of Lap-Band and the clinics that offered the outpatient surgeries. The pitch told prospective patients that they would "get thin" and that it's a routine procedure but that's farthest from reality as the Lap-Band procedure can have serious complications and create disastrous results for the wrong recipients. 

The Lap-Band can migrate from its original location, voiding the purpose of the surgery and putting a recipient in severe pain and at grave risk of serious injuries and maybe death.

The letter from the FDA to oBand Centers orders the company to alter its marketing campaigns, specifically information on its Web site, to call more attention to the side effects and risks of these surgeries. According to the report, "the company's website fails to reveal material facts about Lap-Band risks. The letter also says that a web video that is intended to convey indications for use, contraindications, warnings and adverse events is not accessible to viewers, due to the brief appearance of the information and tiny, blurry print that renders the content illegible."

According to an NBC News report, the hospital is not releasing the name of the surgeon who has been linked to the outbreak. The patients all had heart valve surgeries performed by that same surgeon during the same week in June 2011. The surgeon allegedly had an inflammation on his hand that likely caused the spread of the infection. Hospital administration say that although the surgeon wore gloves, they likely developed "microscopic tears" that allowed the infection to pass to patients during the surgeries.

The patients were all confirmed to be infected with staphylococcus epidermidis bacteria. There is no indication from the NBC report on the clinical outcomes for the infected patients. The surgeon is still employed at Cedars-Sinai Medical Center but is not currently performing surgeries.

News of the outbreak was reported on Sunday this week. The hospital released a statement, according to the report: “We have apologized to the patients involved, worked diligently to answer any questions they have, and provided appropriate follow-up, support and monitoring,” a hospital spokesman said.

These infections and outbreaks are becoming more common as some medical care facilities are forced to make budgetary cutbacks that often affect the sanitary conditions that are supposed to be maintained in a hospital. It also creates staffing crunches that force unqualified doctors to perform surgeries when they either aren't qualified or are physically unable to do so. 

It is likely the victims of the staph infection outbreak will seek legal action for damages they incurred from the medical costs and future injuries they may suffer due to the carelessness during their surgeries. Thousands of surgery patients are injured during their procedures, often due to medical error or unsafe conditions and equipment. 

Kreitchman PET Center, located in Manhattan, New York City, is considered the nation’s leader in the use of positron emission tomography, or PET, for psychiatric research, according to The Times. Pharmaceutical companies provide millions of dollars to the center every year to study drug actions and the biology of brain disorders.

To perform a PET scan, patients must first be injected with a drug called a radiotracer. According to The Times, such drugs are considered very safe, but degrade quickly. As such, many labs make these drugs themselves, following strict FDA protocols which regulate the allowable radiation levels and the purity of the drugs. Drugs that contain impurities can have effects in the body that are unpredictable.

According to The New York Times, an FDA investigation found that researchers at the Kreitchman PET Center routinely injected mental patients with drugs that contained potentially dangerous impurities, repeatedly violating agency regulations over a four-year period. The FDA first wrote to Columbia in December 2008, citing lax internal quality control and sloppy procedures for formulating drug injections. It warned that: “Failure to promptly correct these violations may result in legal action without further notice.”

Then in January 2010, FDA investigators returned and found that many of the Kreitchman PET Center’s lab practices had not changed. The agency cited a long list of specific violations, including one instance in which the staff hid impurities from auditors by falsifying documents, The Times said. One former lab worker told The Times that the FDA “raided the place like it was a crime scene, seizing hard drives.”

According to The Times, during its last investigation, , which took place from Jan. 5 to Jan. 21, the FDA cited six categories of violations. Since 2007, “at least 10 batches” of drugs had been “released and injected into human subjects” with impurities that exceeded the level the lab had agreed to set, investigators said. At least four injections “had impurity masses that more than doubled the maximum limit implemented.” Agency investigators also found a forged document, a hard copy record that had been altered to hide a drug impurity that showed up clearly in the computer records, The Times wrote

The FDA did not make its investigation public.

Many of the patients involved in this type of research suffer from schizophrenia and other brain disorders that make them especially vulnerable to poorly prepared imaging drugs, as these medications may act on the brain receptors involved in their illness, The Times said.

Perhaps one of the most disturbing aspects of The Times report is that, according to former employees interviewed for article, this conduct was commonplace and condoned. They told The Times the center was under “such pressure to produce studies that it papered over and hid impurities in drugs to stretch its resources and went ahead with business as usual despite FDA warnings.”

A resignation letter from one former employee obtained by The Times stated: “These are not the actions of a rogue, but instead are systematic forgeries condoned and approved by the lab director.”

Teva Pharmaceutical Industries and Baxter Healthcare Services have been hit with a $500 million punitive damage judgment in a lawsuit stemming from a hepatitis C outbreak linked to two Las Vegas, Nevada endoscopy clinics. The judgment was the largest jury award in the state’s history.

The hepatitis C outbreak at the center of the lawsuit was traced to the Endoscopy Center of Southern Nevada and its sister clinic, Desert Shadow Endoscopy Center. The Southern Nevada Health District traced nine cases of hepatitis C directly to unsafe injection practices at the outpatient surgical centers, and said 100 others were possibly linked to them. At least 50,000 people were tested for blood-borne diseases because of the clinics’ practices.

According to a Reuters report, plaintiff Henry Chanin claimed he contracted hepatitis C after vials of propofol were reused for his colonoscopy procedure at one of the clinics. Teva made the propofol, and Baxter distributed it, Reuters said. The lawsuit was the first of hundreds of civil lawsuits stemming from a hepatitis C outbreak two years ago.

According to The Las Vegas Review-Journal, Chanin’s lawsuit had alleged the propofol packaging did not include appropriate warnings against reusing vials between patients. The complaint also argued that the 50-milliliter vials of propofol should not have been sold to endoscopy centers because they tempted nurses to reuse the vials instead of throwing away leftover drug.

On Friday, a Clark County District Court jury ordered Teva to pay $356 million and Baxter $144 million. Earlier, the same jury awarded Chanin $5.1 million in compensatory damages.

The doctors and nurses who performed Chanin’s colonoscopy were also named in his lawsuit, but settled those claims earlier, the Review-Journal said.

Both Teva and Baxter say they plan to appeal the verdict.

Sadly, the Times investigation revealed that radiation overdoses are more common than some might think.  The investigation uncovered 621 mistakes involving radiation treatment errors from 2001 to 2008 at hospitals in New York State. In 133 of the cases, the devices used to shape or modulate radiation beams were left out, wrongly positioned or otherwise misused. In 284 cases, the investigation found radiation missed all or part of its intended target or treated the wrong body part entirely.

According to the Times, radiation errors were most often attributed to “software flaws, faulty programming, poor safety procedures or inadequate staffing or training.”

Unfortunately, the Times found that patients in New York are unable to vet the radiotherapy center where they get treatment because the state does not disclose where or how often medical mistakes occur. What’s more, fines or license revocations are rarely used to enforce safety rules. According to the Times, New York State issued just three fines against radiotherapy centers over the past eight years, the largest of which was $8,000.

The Times article also highlights two patients who suffered greatly because of radiation overdoses. In one case, a 43-year-old man died in 2007, following radiation treatments at St. Vincent’s Hospital in Manhattan for tongue cancer. The hospital failed to detect a computer error that directed a linear accelerator to blast his brain stem and neck with errant beams of radiation – on three consecutive days. Prior to his death, the radiation overdoses left the man in severe pain, deaf, struggling to see, nauseated and unable to swallow. He sustained burns, and the radiation caused his teeth to fall out and ulcers his mouth and throat.

I another case, a 32-year-old mother of two with breast cancer received three times the recommended dosage of radiation during all 27 scheduled treatments at the State University of New York Downstate Medical Center in Brooklyn because a therapist incorrectly programmed the linear accelerator. She was left with a gaping wound so painful that she considered suicide, the Times said. Her cancer returned while she was being treated for the wound, and ultimately proved fatal.

Now, says the Associated Press (AP), the hospital has been fined $150,000 and mandated to take what the AP described as “the extraordinary step” of putting in video cameras in its operating rooms, citing Rhode Island health officials. The unprecedented move involves a nonsurgical team clinician observing hospital surgeries for one year, monitoring if surgeons are marking operation sites, and taking time outs to determine if the correct body part has been located for surgery, said the AP.

Rhode Island Hospital has 45 days to install the recording equipment in its operating rooms and every doctor will be taped during surgery at least twice a year, reported the AP. It will be at the hospital’s discretion to advice surgeons if they are being monitored.

Health officials and the State Department of Health were looking into how a surgeon at the hospital mistakenly operated on the wrong area of a patient’s hand. That alleged mistake represented the fifth such wrong-site surgery in two years at the hospital, a teaching hospital for Brown University’s Alpert Medical School. According to state health director, David Gifford, the $150,000 fine represents the second such fine in as many years, said the AP. The prior fine, for $50,000, was imposed following three wrong site neurosurgeries in 2007, added the AP, noting that, according to Gifford, these are the only two fines ever issued by his department.

While this was the third wrong-site surgery in one year, Rhode Island News reported that that surgery was the fourth wrong-site surgery in just six years, all taking place in the neurosurgery area.

The recent surgery, based on a letter previously cited by the AP, revealed that Hospital President Timothy Babineau said the error occurred late last week on a patient scheduled to undergo surgery on two fingers meant for a joint on one of the fingers, but operated on another finger. Babineau said, reported the AP, the surgery was then performed on the correct finger. The patient has since been released.

According to the AP’s recent report providing additional details on the scandal, the surgery was meant for two fingers; however the surgeon performed two operations on the same finger. The site of the planned surgery was to have been indicated, with the team ensuring—prior to making an incision—that they were operating on the correct patient, the correct procedure, and the correct body part, said the AP. The protocols are long established in the medical field and also include marking of the body part scheduled for the operation.

According to Gifford, the surgical team marked the wrist, not each of the two fingers; the surgeon did not mark the site, and the team did not take a “time-out” prior to the second surgery, said the AP. Apparently, when the error was discovered, the team confirmed with the family of the patient if they should conduct the correct surgery on the correct site, said the AP, but—astonishingly—even after the mistakes already made, the team still did not conduct the recommended timeout, a mistake Gifford described as “amazing.”

• Phase 1, which began in July 2009, is to design and implement a Web based questionnaire to assess patient-reported outcomes and evaluate quality of life issues post-LASIK, some of which may relate to the safety of the lasers used in the LASIK procedure.
• Phase 2 will evaluate the quality of life and satisfaction following LASIK as reported by patients in a select, active duty population treated at the Navy Refractive Surgery Center.
• Phase 3 will be a national, multi-center clinical trial and will study the impact of the procedure on quality of life following LASIK in the general population. Patient enrollment in Phases 2 and 3 have yet to begin but plans are underway. Phase 3 is expected to end in 2012.

But, Kao, who admitted to “missing his target” when performing brachytherapy, claimed this type of error is not unusual and something for which he refused to be singled out, reported the Associated Press (AP). “Contrary to the allegations that I was a ’rogue’ physician, ... I always acted in the best interest of the patients in delivering this important treatment,” said Kao, quoted the AP. Kao, a radiation oncologist, was quoted when testifying at a Senate field hearing at the hospital, said the AP, noting that Kao worked at the VA center from 2002 to 2008.

KYW1060 reported that Kao testified that it is understood that radioactive seeds can move outside of the prostate to tissue and other organs, "The chance of seeds in the bladder, or outside the prostate, is a recognized risk of the procedure," said Kao. Senator Arlen Specter asked Kao at this point, "It's a recognized risk, but did you notify patients?" quoted KYW1060, to which Kao responded, "No sir.” Kao claimed such errors did not constitute a lower level of care that required reporting to the Nuclear Regulatory Commission (NRC) and other agencies, said the AP. “Brachytherapy was and still is an evolving field,” claimed Kao, quoted the AP.

The prostate is the size of a walnut and is located near the bladder and rectum, said the AP. Brachytherapy involves implantation of radioactive seeds to kill cancer cells, explained the AP previously, noting that most veterans allegedly received ‘”significantly less” dosing than what was prescribed, while others “received excessive radiation to nearby tissue and organs.” Brachytherapy is an option only used in patients diagnosed with “small, early-stage, non-aggressive prostate cancers,” said Philly.com.

According to an earlier AP report, the team performing the brachytherapy “botched” dosing on most cases, but continued to conduct treatment despite that “monitoring equipment was broken,” citing The New York Times. The AP reported that the NRC found incorrect dosing occurred because, generally, seeds landed outside of the prostate in tissue or nearby organs. Kao performed most procedures, said Philly.com, noting that Kao stopped seeing patients a year ago.

In one case, a patient testified to losing his job because he was forced on five months bed rest after Kao allegedly implanted radiation seeds into his rectum, not his prostate, said the AP. Although the VA said the problem likely came from hemorrhoids or constipation, an Ohio State University physician diagnosed the problem as radiation burn, surgically correcting the problem, the AP reported.

In another case, a patient underwent a seed removal from his bladder, alleged that three seeds were expelled in blood clots, and suffered radiation irritation to his rectum and bladder. The patient claims he never received the VA letter allegedly sent to all its brachytherapy patients. The cancer remains and the patient’s options are significantly limited and include surgery to remove the prostate, bladder, and colon, forcing use of urine and feces collection bags, said Philly.com.

The VA center’s brachytherapy program has been suspended, said the AP, noting that a review of 12 other VA hospitals in which brachytherapy is conducted revealed some problems, as well; none allegedly as severe or frequent as at the center in Philadelphia. According to the AP, Kao took a leave from the University of Pennsylvania last week.

ECanadaNow.com noted that release of the report may enable more rest for resident.  Today, residents are exhausted when treating patients, which could result in “serious medical errors.”  The vast majority of residents—a whopping 75 percent—reported being “burnt out” before ever reaching the 80-hour weekly limit, said ECanadaNow, which noted that even 30-hour shifts might be excessive.

According to the Associated Press (AP) noted, regulations passed in recent years limited the amount of hours residents were allowed to work to 80 per week.  However, the recent Institute of Medicine’s report entitled, “Resident Duty Hours: Enhancing Sleep, Supervision and Safety” indicates that residents are still too tired and their hospitals should provide opportunities for trainees to get some rest.

USA Today noted that it was the Accreditation Council for Graduate Medical Education (ACGME), the organization that is responsible for residency programs that instituted the 80-hour-per-week limit back in 2003.  That limit, said USA Today, was to be averaged over a four-week period and should ensure that no more than 30 hours be worked at any given time.  In the past, residents typically worked over 100 hours or more weekly, said USA Today.

Yesterday, an Institute panel recommended that those individuals working the “maximum 30-hour shift should get an uninterrupted five-hour break for sleep after 16 hours,” the AP said.   “Our committee's charge was not to focus necessarily on longer scheduling or shorter scheduling, but smarter scheduling to try to really identify the areas where we could have an impact in preventing excessive fatigue, both acute and chronic, that might contribute to medical errors,"  panel member Dr. Daniel Munoz of Johns Hopkins University School of Medicine told the AP.

The Salt Lake Tribune spoke with surgery intern Brent James, who said he often worked 90-to-120-hour weeks, taking late night calls he was unable to remember the following day.  James has since been elected to the Institute and agrees with the call for reduced resident work hours, which are expected to improve training and reduce the chances of fatigue-related medical errors.  "We know that if people are too tired they will make mistakes,"  James told the Tribune.

The Tribune noted that the Institute report suggests that residents not work long hours without rest, moonlighting be restricted, and residents take more days off.  However, the Institute did not suggest a change to the 2003 80-hour-per-week maximum.  The Tribune pointed out that despite the cap on weekly hours, the 80-hour limit is often exceeded, indicating closer ACGME monitoring might be called for.

Although some feel additional reductions might hinder residents’ training, the AP quoted Rebecca Sadun of the American Medical Student Association who said the recommendations are "unambiguously a step in the right direction.  Sadun cited the current limits as being “insufficient” as they do not allow residents sufficient rest throughout the course of their shifts.

The Food & Drug Administration (FDA) rejects about 1/3 of all proposed new drug names every year because they sound or look too similar.  Unfortunately, this has not entirely eliminated the problem, mainly because there are so many drugs on the market. It is just too difficult to track them all. 

Many drug-mix ups involving medications with similar names occur because a pharmacist cannot read a doctor's handwriting on a prescription.  But even when doctors employ computerized prescriptions, errors can occur if a physician, for example, clicks on "Actos" when he or she meant to select "Actonel".  In other instances, a pharmacist may be at fault, if drugs are not alphabetized properly and she grabs the wrong one. 

On a few occasions, mix-ups involving similar sounding medications have been so frequent that the names of drugs have been changed.  For example,  according to the Associated Press, the Alzheimer's drug Reminyl now is named Razadyne, after mix-ups, including two reported deaths, with the old diabetes drug Amaryl. The cholesterol pill Omacor is now named Lovaza, after mix-ups with blood-clotting Amicar.

But changing medication names to avoid mix-ups is hardly efficient.  So now, several initiatives are underway to deal with the problem.  According to the Associated Press, last week Pharmacopia opened a Web-based tool to let consumers and doctors easily check if they're using or prescribing any of these error-prone drugs, and what they might confuse it with.

The Associated Press also reports the FDA is preparing a pilot program that would shift more responsibility to manufacturers to guard against name confusion. The FDA is trying to find ways that drug makers can better test for potential mix-ups before they seek approval for their products.

There are also things consumers can do to protect themselves from such medication errors.  For one thing, patients  should question the pharmacist if the tablets look different than last time.  It is also wise to ask a doctor to write a diagnosis on the prescription.  For instance, writing "for heart" next to "clonipine," could prevent a pharmacist from dispensing the gout medicine colchicine, or Klonopin which is for seizures.

Tight glucose control involves nurses testing patients' blood-sugar levels hourly, and, if required, adjusting intravenous insulin drips.  The treatment began being heavily promoted by medical groups such as the Surviving Sepsis Campaign back in 2004.  That promotion was prompted on one study, which took place in Belgium that indicated that critical-care patients often had high blood sugar that could lead to fatal complications.

Sepsis is a bloodstream infection that can result in death by causing multiple organ failure. The Surviving Sepsis Campaign is a larger group that includes the American Thoracic Society, the Society of Critical Care Medicine, and the American College of Emergency Physicians.  At its urging, and following the single 2001 Belgium study of 1,548 patients, hospitals adopted the glucose-control treatment.  That single study concluded that tight glucose control treatment reduced the death rate in the hospital's surgical intensive-care unit to 4.6% of total critical-care patients from 8.0%.

The Dartmouth researchers found that the glucose-control treatment failed to save more lives than standard sepsis therapy, such as antibiotics, fluids, and blood-pressure medicines.  The researchers also found that the treatment significantly increased the incidence of hypoglycemia—low blood sugar—which, in extreme cases, can lead to coma and seizures that can trigger devastating brain damage.  "In critically ill adult patients, tight glucose control is not associated with significantly reduced hospital mortality but is associated with an increased risk of hypoglycemia," Dartmouth researchers reported in Wednesday's Journal of the American Medical Association.  "Overall, it seems that the time has come to reconsider whether professional societies should continue to recommend tight glucose control as the standard of care in all critically ill adults," said Renda Soylemez Wiener, a critical-care doctor and lead author of the study.

The research revealed that glucose-control therapy had no significant effect on death rates; that hypoglycemia was multiplied five-fold among patients on the therapy; and that glucose-control treatment was linked to a modest reduction in sepsis infection.  The researchers also pointed out that, "Hypoglycemia is not benign in critically ill patients.  "It has been linked to serious neurologic events ranging from seizures to coma."

In January, the New England Journal of Medicine published a German study of 537 patients from multiple hospitals in which severe sepsis patients were randomly assigned to intensive insulin therapy such as tight glucose control, or to standard treatment. The trial was stopped early for safety reasons, including a four-fold increase in hypoglycemia and a doubling of serious adverse events. Those researchers concluded that intensive insulin therapy "placed critically ill patients with sepsis at increased risk for serious adverse events related to hypoglycemia.”

If you or a loved one has been victimized by medical malpractice or medical negligence, Parker Waichman LLP urges you to contact one of our medical malpractice attorneys by completing the form at right or call us at 1-800-LAW-INFO(1-800-529-4636) immediately. Our compassionate and committed medical malpractice lawyers are dedicated to helping the victims of medical malpractice get their lives back on track.

Medical malpractice injures thousands of people every year. Medical malpractice is the failure of a medical professional or facility to meet the standard of good medical practice in the areas in which the medical professional or medical facility specializes. A medical professional may be a doctor, a nurse, a medical technician, or other health care provider. A medical facility may be a hospital, nursing home, medical testing facility or clinic. If good medical standards are not met, harm may result to a patient and the medical professional or facility my be liable for any resulting damages and injuries that may cause lifelong medical bills, loss of income or death.

According to an article published in the Journal of the American Medical Association (JAMA), over 225,000 people die yearly due to medical malpractice, with nearly half of the deaths occurring in hospital emergency rooms. Medical malpractice has become the third leading cause of deaths in the United States. Additionally, a Harvard Medical School study found that over 5% of all hospital patients were injured as a result of medical malpractice.

How Large Is The Problem of Medical Malpractice?

In 1990, according to a Harvard Medical Practice study, approximately 80,000 people die due to medical malpractice making it a much greater problem than most people realize. This figure is based on the extensive study “Patients, Doctors and Lawyers: Medical Injury, Malpractice Litigation, and Patient Compensation in New York,”. While these medical malpractice statistics are alarming, it is even more disturbing that these statistics do not even include medical malpractice deaths that have occurred in clinics, private doctors offices, or other treatment facilities.

Are Medical Malpractice Lawsuits Common?

While medical malpractice numbers are staggering only a few claims are filed. The Harvard Medical Practice Study found that only one in eight patients that suffers due to medical malpractice ever files a lawsuit and concluded that medical malpractice is not accessible enough for medical malpractice victims, including birth injury and other cases of negligence. A New England Journal of Medicine article analyzed malpractice data from 1991 through 2005 and found that each year during the study, 7.4% of all physicians had a malpractice claim and only 1.6% had a claim that led to a payment. Having been successful at representing and obtaining compensation for medical malpractice victims, Parker Waichman LLP urges you to contact us by completing the form at the right or call us at 1-800-LAW-INFO (1-800-529-4636) if you feel that you or a loved have been injured by medical error or negligence.

Medical Malpractice Victims - Legal Help

If you are seeking a medical malpractice lawyer, Parker Waichman LLP has successfully represented medical malpractice victims that have been injured due to medical errors or negligence including dental malpractice, nursing home and hospital negligence. The attorneys at Parker Waichman LLP have represented clients in medical malpractice cases across the State of New York, including the boroughs of Manhattan, Brooklyn, Bronx, Queens, Staten Island and Westchester. Parker Waichman LLP has offices in Nassau and Suffolk County. Parker Waichman LLP also represents victims of medical negligence in New Jersey, Washington, D.C., Maryland and Florida.

The links below are a few of the medical malpractice claims Parker Waichman LLP has represented for our clients. Please visit the links for more information regarding the medical negligence claims and feel free to contact us if you feel that you or a loved one have been harmed by a physician or other medical professional due to medical malpractice or negligence.